Bavarian Nordic A/S (BVNRY)
OTCMKTS
· Delayed Price · Currency is USD
7.63
0.00 (0.00%)
Mar 28, 2025, 4:00 PM EST
Bavarian Nordic Employees
Bavarian Nordic had 1,605 employees as of December 31, 2024. The number of employees increased by 226 or 16.39% compared to the previous year.
Employees
1,605
Change (1Y)
226
Growth (1Y)
16.39%
Revenue / Employee
$494,415
Profits / Employee
$85,454
Market Cap
1.79B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 116 |
American Oncology Network | 1,525 |
Bavarian Nordic News
- 12 days ago - Widely used drugs on US imports list from Europe - Reuters
- 19 days ago - Bavarian Nordic A/S – Notice Convening Annual General Meeting - GlobeNewsWire
- 24 days ago - Bavarian Nordic Announces Acceptance of Marketing Authorization Application for Chikungunya Vaccine in the UK for Persons Aged 12 and Older - GlobeNewsWire
- 25 days ago - Bavarian Nordic A/S (BVNKF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 26 days ago - Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such - GlobeNewsWire
- 26 days ago - Bavarian Nordic Publishes Annual Report 2024 - GlobeNewsWire
- 4 weeks ago - Bavarian Nordic Receives Marketing Authorization in Europe for Chikungunya Vaccine for Persons Aged 12 and Older - GlobeNewsWire
- 4 weeks ago - Biological E in strategic pact with Danish co Bavarian Nordic to manufacture Chikungunya vax for global access - The Times of India